Research Article
Botulinum Toxin Injection with Conjunctival Microincision for the Treatment of Acute Acquired Comitant Esotropia and Its Effectiveness
Table 3
Clinical profile of study population.
| Variable | Mean | Standard deviation | Range |
| Age at onset (years) | 14.2 | 7.4 | 4–34 | Onset to BTXA(wks) | 18.4 | 20.3 | 1–96 | Spherical equivalent right eye | −1.22 | 2.85 | −7.50 to +2.00 | Spherical equivalent left eye | −0.97 | 2.80 | −7.50 to +2.25 | Follow-up period (mos) | 12.3 | 4.8 | 7–24 |
|
|
BTXA: botulinum toxin A.
|